首页> 外文OA文献 >Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications
【2h】

Incomplete DJH rearrangements of the IgH gene are frequent in multiple myeloma patients: immunobiological characteristics and clinical implications

机译:IGH基因的不完全DJH重排在多发性骨髓瘤患者中经常出现:免疫学特征和临床意义

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

DH-JH rearrangements of the Ig heavy-chain gene (IGH) occur early during B-cell development. Consequently, they are detected in precursor-B-cell acute lymphoblastic leukemias both at diagnosis and relapse. Incomplete DJH rearrangements have also been occasionally reported in mature B-cell lymphoproliferative disorders, but their frequency and immunobiological characteristics have not been studied in detail. We have investigated the frequency and characteristics of incomplete DJH as well as complete VDJH rearrangements in a series of 84 untreated multiple myeloma (MM) patients. The overall detection rate of clonality by amplifying VDJH and DJH rearrangements using family-specific primers was 94%. Interestingly, we found a high frequency (60%) of DJH rearrangements in this group. As expected from an immunological point of view, the vast majority of DJH rearrangements (88%) were unmutated. To the best of our knowledge, this is the first systematic study describing the incidence of incomplete DJH rearrangements in a series of unselected MM patients. These results strongly support the use of DJH rearrangements as PCR targets for clonality studies and, particularly, for quantification of minimal residual disease by real-time quantitative PCR using consensus JH probes in MM patients. The finding of hypermutation in a small proportion of incomplete DJH rearrangements (six out of 50) suggests important biological implications concerning the process of somatic hypermutation. Moreover, our data offer a new insight in the regulatory development model of IGH rearrangements.
机译:IG重链基因(IGH)的DH-JH重排在B细胞发育期间发生。因此,在诊断和复发中,在前体-B细胞急性淋巴细胞白血病中检测它们。在成熟的B细胞淋巴抑制性疾病中,也偶尔报告了不完全的DJH重排,但尚未详细研究其频率和免疫学特性。我们研究了不完全DJH的频率和特征,以及一系列84个未处理的多发性骨髓瘤(MM)患者的完整VDJH重排。通过使用家庭特异性引物扩增VdjH和DJH重排的总克隆的总体检测率为94%。有趣的是,我们发现该组中的DJH重排频率高(60%)。从免疫学的角度来看,绝大多数DJH重排(88%)未被制成。据我们所知,这是第一个系统研究,描述了一系列未选择的MM患者中不完全DJH重排的发病率。这些结果强烈支持使用DJH重排作为克隆性研究的PCR靶标,特别是通过使用MM患者的共有JH探针进行实时定量PCR来定量最小的残留疾病。在小比例的不完全DJH重排(50分)中,查找较小比例的高度突出表明了关于各种各样的躯体超责任过程的重要生物学意义。此外,我们的数据为IHRE重排的监管开发模式提供了新的洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号